Literature DB >> 2689438

Deletion of a highly conserved tetrapeptide sequence of the proinsulin connecting peptide (C-peptide) inhibits proinsulin to insulin conversion by transfected pituitary corticotroph (AtT20) cells.

D J Gross1, L Villa-Komaroff, C R Kahn, G C Weir, P A Halban.   

Abstract

The biological function of the connecting peptide (C-peptide) of proinsulin is unknown. Comparison of all known C-peptide sequences reveals the presence of a highly conserved peptide sequence, Glu/Asp-X-Glu/Asp (X being a hydrophobic amino acid), adjacent to the Arg-Arg doublet at the B chain/C-peptide junction. Furthermore, the next amino acid in the C-peptide sequence is also acidic in many animal species. To test the possible involvement of this hydrophilic domain in insulin biosynthesis, we constructed a mutant of the rat proinsulin II gene lacking the first four amino acids of the C-peptide and expressed either the normal (INS) on the mutated (INSDEL) genes in the AtT20 pituitary corticotroph cell line. In both cases immunoreactive insulin (IRI) was stored by the cells and released upon stimulation by cAMP. In the INS expressing cells, the majority of IRI, whether stored or released in response to a secretagogue, was mature insulin. By contrast, most of the stored and releasable IRI in the INSDEL expressing cells appeared to be (mutant) proinsulin or conversion intermediate with little detectable native insulin. Release of the mutant proinsulin and/or conversion intermediates was stimulated by cAMP. These results suggest that the mutant proinsulin was appropriately targeted to secretory granules and released predominantly via the regulated pathway, but that the C-peptide deletion prevented its conversion to native insulin.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2689438

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Proinsulin conversion intermediates: a possible source of confusion.

Authors:  P A Halban
Journal:  Diabetologia       Date:  1991-03       Impact factor: 10.122

Review 2.  Sorting and processing of secretory proteins.

Authors:  P A Halban; J C Irminger
Journal:  Biochem J       Date:  1994-04-01       Impact factor: 3.857

3.  Proinsulin endoproteolysis confers enhanced targeting of processed insulin to the regulated secretory pathway.

Authors:  R Kuliawat; D Prabakaran; P Arvan
Journal:  Mol Biol Cell       Date:  2000-06       Impact factor: 4.138

4.  Levels of the conversion endoproteases PC1 (PC3) and PC2 distinguish between insulin-producing pancreatic islet beta cells and non-beta cells.

Authors:  M Neerman-Arbez; V Cirulli; P A Halban
Journal:  Biochem J       Date:  1994-05-15       Impact factor: 3.857

5.  Sequence requirements for processing of proinsulin in transfected mouse pituitary AtT20 cells.

Authors:  N A Taylor; K Docherty
Journal:  Biochem J       Date:  1992-09-01       Impact factor: 3.857

Review 6.  Structural domains and molecular lifestyles of insulin and its precursors in the pancreatic beta cell.

Authors:  P A Halban
Journal:  Diabetologia       Date:  1991-11       Impact factor: 10.122

7.  Sequence requirements for proinsulin processing at the B-chain/C-peptide junction.

Authors:  J E Kaufmann; J C Irminger; P A Halban
Journal:  Biochem J       Date:  1995-09-15       Impact factor: 3.857

8.  Differential rates of conversion of rat proinsulins I and II. Evidence for slow cleavage at the B-chain/C-peptide junction of proinsulin II.

Authors:  S V Sizonenko; P A Halban
Journal:  Biochem J       Date:  1991-09-15       Impact factor: 3.857

Review 9.  Proinsulin processing in the regulated and the constitutive secretory pathway.

Authors:  P A Halban
Journal:  Diabetologia       Date:  1994-09       Impact factor: 10.122

Review 10.  Insulin secretory granule biogenesis and the proinsulin-processing endopeptidases.

Authors:  J C Hutton
Journal:  Diabetologia       Date:  1994-09       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.